Literature DB >> 20110665

Immobilized kidney 28-kDa endostatin-related (KES28kDa) fragment promotes endothelial cell survival.

Maria Helena Bellini1, Thiago França Malpighi, Fernanda Bernardes Calvo, Adriana Regina Miranda, Patrick Jack Spencer, Milena Cristina Cichy, Simone Michaela Simons, Ana Marisa Chudzinski Tavassi, Marinilce Fagundes dos Santos, Consuelo Junqueira Rodrigues, Nestor Schor.   

Abstract

BACKGROUND/
OBJECTIVE: Renal ischemia-hypoxia is a leading cause of acute kidney injury (AKI). Ischemia causes extracellular matrix breakdown of the tubular basement membrane. Endostatin (ES) is the C-terminal fragment of collagen XVIII generated by proteolytic cleavage. Recent studies have demonstrated that ES expression is upregulated in ischemic kidneys. The present study aimed to characterize ES from ischemic kidneys.
METHODS: Ischemic renal failure was induced via 45 min of occlusion of the left renal artery and vein. After the ischemic period, blood was collected. Kidneys were harvested and used for immunohistochemical testing and protein extraction. Three-step purification was used. Soluble and immobilized purified ES were tested in cell viability and adhesion assays. results: The soluble KES28kDa inhibited endothelial cell proliferation: 25 versus 12.5 microg (p < 0.05); 12.5 versus 3.15 microg (p < 0.05). Immobilization of KES28kDa supports endothelial cell survival over the control (p = 0.021). Human umbilical vein endothelial cells plated on immobilized KES28kDa showed an increase in membrane ruffles and stress fibers.
CONCLUSION: These data demonstrate the local synthesis of a 28-kDa ES-related fragment following AKI and suggest its role in endothelium survival. 2010 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20110665     DOI: 10.1159/000278756

Source DB:  PubMed          Journal:  Am J Nephrol        ISSN: 0250-8095            Impact factor:   3.754


  3 in total

1.  Plasma endostatin predicts kidney outcomes in patients with type 2 diabetes.

Authors:  Kinsuk Chauhan; Divya Anna Verghese; Veena Rao; Lili Chan; Chirag R Parikh; Steven G Coca; Girish N Nadkarni
Journal:  Kidney Int       Date:  2018-12-24       Impact factor: 10.612

2.  Plasma endostatin may improve acute kidney injury risk prediction in critically ill patients.

Authors:  Johan Mårtensson; Niklas Jonsson; Neil J Glassford; Max Bell; Claes-Roland Martling; Rinaldo Bellomo; Anders Larsson
Journal:  Ann Intensive Care       Date:  2016-01-13       Impact factor: 6.925

3.  Derivation and validation of plasma endostatin for predicting renal recovery from acute kidney injury: a prospective validation study.

Authors:  Hui-Miao Jia; Yue Zheng; Li-Feng Huang; Xin Xin; Wen-Liang Ma; Yi-Jia Jiang; Xi Zheng; Shu-Yan Guo; Wen-Xiong Li
Journal:  Crit Care       Date:  2018-11-16       Impact factor: 9.097

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.